Given its steady pipeline of accretive acquisition opportunities ahead, Wunderlich’s Craig Kucera believes Global Medical REIT Inc GMRE “should be able to drive earnings growth while garnering multiple expansion as the company increases its market capitalization.”
Kucera initiated coverage of the company with a Buy rating and price target of $11.75.
Serving An Underserved Space
The analyst explained that Global Medical REIT offered financial services for medical practitioners, seeking out only high acuity licensed medical facilities, which are an underserved niche in the public healthcare REIT space.
“As such, competition is more limited and management can enter into sale-leaseback transactions where they are able to craft leases with more attractive terms and better pricing,” Kucera stated.
Kucera also believes management has built relationships that allow the company to consistently source a meaningful number of off-market, acute care acquisitions that are accretive to Global Medical REIT’s cost of capital.
This in turn helps drive earnings growth, while the company is expected to see multiple expansion as it increases its market capitalization.
Superior Returns
The analyst also pointed out that the acute care niche offers the company superior risk-adjusted returns.
“The initial portfolio GMRE contributed to the REIT has rent coverage in excess of 7x and operator distributions are subordinate to payment of rent,” Kucera noted.
Did you like this article? Could it have been improved? Please email feedback@benzinga.com to let us know!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.